Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,620 stories, page 153 of 611

Advanced search

🇺🇰Aug 29Regulatorygov.ukTier 1 · Regulatory source

Terminally Ill Adults (End of Life) Bill 2026: impact assessment

The impact assessment considers the potential impacts of the Terminally Ill Adults (End of Life) Bil...

UK Department of Health and Social CareOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Cipla Pune Unit Loses Drug Sale Licences: What Triggered FDA Action?

outlookbusiness.comOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

TipRanksOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Fenwick partners see biotech IPO demand building

AxiosOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Bengaluru’s ‘Peptide Party’ cancelled after Karnataka Food Safety and Drug Administration seeks...

Moneycontrol.comOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe-Led Maharashtra FDA Cancels Cipla Unit's Drug Licence Over Reactin Plus Irregularities

MenafnOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Best Biotech Stocks To Research - August 28th

MarketBeatOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Here’s why Maharashtra FDA cancelled drug sale licence of Cipla’s Pune unit

The StatesmanOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Cancels Cipla Facility Drug Licences Over Reactin Plus Irregularities

English Bombay SamacharOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Biotech companies bring on new HR talent in August

HR DiveOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Moderna and Merck’s positive preliminary cancer vaccine results could signal a ‘new era’ of cancer treatment, expert says

Healthcare BrewOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe-led Maharashtra FDA cancels Cipla unit's drug licence over Reactin Plus irregularities

LivemintOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals?

Currently.comOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals?

The Globe and MailOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Cipla Pune unit’s drug sale licence over violations

Zee NewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Show Me The Money: CADL Delivers 190%+ Gain In Less Than Six Months As BLA Filing Nears

RTTNewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Bank of America sees major upside in this biotech stock

thestreet.comOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Cytokinetics Shares Drop 5% Even as Company Delivers First Positive Phase 3 Results in Non-Obstructive HCM

TechStock²Original source

🌍Aug 28Regulatorywho.intTier 1 · Regulatory source

Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo

WHO Disease Outbreak NewsOriginal source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs

STATOriginal source

🇺🇸Aug 28Industryinvestor.lilly.comTier 1 · Company source

La FDA aprueba Mounjaro (tirzepatida) de Lilly para reducir el riesgo cardiovascular en adultos con diabetes tipo 2

Eli Lilly NewsOriginal source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

This week in charts: Biotech’s rebound is undeniable

BioPharma DiveOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

FDA cancels Cipla pharma’s CFA drug sale licence in Pune

The Indian ExpressOriginal source

🇺🇸Aug 28CROwcgclinical.comTier 2 · Direct publisher

FDA’s Updated IND Safety Reporting Guidance: What Changed, What Didn’t, and What to Do Now

WCG (IRB)Original source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

India News | Maharashtra FDA Cancels Licence of Prominent Pharma Company in Pune

LatestLYOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Cancer drug trial shows no sign of tumors—here's what happens next

NewsweekOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Pune pharma firm’s drug sale licences

The News MillOriginal source

🇪🇸Aug 28Researchcrg.euTier 2 · Direct publisher

Self-blinking ‘fairy lights’ allow DNA to be imaged at double helix width resolution

CRG Barcelona GenomicsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels licence of prominent pharma company in Pune

ANI NewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Annex 1 turns three: spotlight on sterile manufacturing

The Pharma LetterOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Cancels Cipla Pune Unit’s Drug Licence Over Reactin Plus Lapses

Republic WorldOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Weekly Buzz: GILD, ROIV Win FDA Nod; BHVN, LLY Strike Deal; SYRE Misses Monotherapy Goal

RTTNewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Has Ultragenyx Pharmaceutical (RARE) Fallen Far Enough After Gene Therapy Approval?

simplywall.stOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Cipla unit's drug licences in Pune over Reactin Plus recall, storage lapses

India TV NewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Miami Biotech Collective Rings the Nasdaq Stock Market Opening Bell

NasdaqOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Clinical trial tests new way to treat common inherited heart disease

OHSU NewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Cancels Drug Sale Licences Of Cipla Pharma & Life Sciences’ Pune C&F Unit Over Reactin Plus

Free Press JournalOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

FDA cancels Cipla Pune unit's licence over Reactin Plus violations; firm contests

India TodayOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Viking Therapeutics Stock (VKTX) Opinions on Phase 3 Obesity Drug Data Timing

Quiver QuantitativeOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Cipla Pharma’s Pune drug licences, seizes ₹11.19 lakh stock

CNBC TV18Original source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Cipla Pharma’s Pune unit drug sale licence

CNBC TV18Original source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

FDA cancels drug sale licences of Cipla Pharma & Life Sciences's Pune Carry and Forwarding unit

DailyhuntOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violation

The Economic TimesOriginal source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

STATOriginal source

🇪🇺Aug 28Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Standardized patient‑friendly computational language mapping to guide epilepsy surgery

CORDISOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

FDA cancels drug sale licences of Cipla Pharma & Life Sciences' Pune Carry and Forwarding unit

The HinduOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Misbranding, storage lapses: FDA cancels Cipla Pune unit’s drug licence over Reactin Plus violations

The Times of IndiaOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Trump's pick for FDA faces scrutiny after cyclospora outbreak

BBCOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Biotech firms point to sustainability benefits of NGTs

FruitnetOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

New Haven biotech BioXcel files for bankruptcy, agrees to potential $145M sale

Hartford Business JournalOriginal source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio

Fierce BiotechOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

LIVE: Miami Biotech Collective Rings the Opening Bell

NasdaqOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

mRNA Cancer Vaccine Met Endpoints in Adjuvant Melanoma

Oncology Nursing NewsOriginal source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

Fierce Pharma Asia—Roche’s $2.5B obesity deal; Akeso CEO’s defense; Lawmaker’s reflection on China

Fierce PharmaOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Symbiosis Pharmaceutical Services appoints Jay Chima as VP - business development in response to growing demand for biologics

Pharmabiz.comOriginal source

🇺🇸Aug 28Regulatoryfda.govTier 1 · Regulatory source

Withdrawn CDER Product Specific Guidances

FDA Drug Safety CommunicationsOriginal source

🇺🇰Aug 28Researchquadram.ac.ukTier 2 · Direct publisher

Quadram Institute announces Dr Perry Bateman as new Director of Operations

Quadram Institute (Bioscience)Original source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push

Fierce BiotechOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Florida to sue two big pharmaceutical companies

fox10tv.comOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Should Income Investors Look At Middle East Pharmaceutical Industries Company (TADAWUL:4016) Before Its Ex-Dividend?

simplywall.stOriginal source